Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Crossref
1. Novel scores combining AFP with non‐invasive markers for prediction of liver fibrosis in chronic hepatitis C patients
- Mohamed Gamil
- Mohamed Alboraie
- Mohammad El‐Sayed
- Aisha Elsharkawy
- Noha Asem
- Tamer Elbaz
- Mohammad Mohey
- Bahaa Abbas
- Mai Mehrez
- Gamal Esmat
2. Pathology Predictors of Response to Combined Therapy of Chronic HCV Patients; Is it Applicable in the DAA Era?
- Samar Kamal Darweesh
3. Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study
- Mohamed Said
- Zeinab Soliman
- Hosam Daebes
- Saeed M El-Nahaas
- Magdy El-Serafy
4. Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C
- Masaya Saito
- Yoshihiko Yano
- Hirotaka Hirano
- Kenji Momose
- Masaru Yoshida
- Takeshi Azuma
5. Data Mining and Machine Learning Algorithms Using <i>IL28B</i> Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C
- Hend Ibrahim Shousha
- Abubakr Hussein Awad
- Dalia Abdelhamid Omran
- Mayada Mohamed Elnegouly
- Mahasen Mabrouk
6. Changes in serum interferon-γ-inducible protein-10 levels and liver stiffness among chronic hepatitis C Egyptian patients in response to directly acting antiviral agents
- Saeed M. El-Nahaas
- Normeen Hany Rady
- Shimaa Malek
- Khaled Serag
7. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV‐genotype 4 in Egypt
- P. Bonnard
- A. Elsharkawy
- K. Zalata
- E. Delarocque‐Astagneau
- L. Biard
- L. Le Fouler
- A. B. Hassan
- M. Abdel‐Hamid
- M. El‐Daly
- M. E. Gamal
- M. El Kassas
- P. Bedossa
- F. Carrat
- A. Fontanet
- G. Esmat
8. Comparative study between liver biopsy and non-invasive biomarkers in assessment of hepatic fibrosis in children with chronic liver diseases
- Ola Galal Behairy
- Ola Samir El-Shimi
- Naglaa Hamed Shalan
9. Value of Egy‐Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase‐to‐platelet ratio index, FIB‐4 and Forns' index in chronic hepatitis C virus
- Mohamed Alboraie
- Marwa Khairy
- Marwa Elsharkawy
- Noha Asem
- Aisha Elsharkawy
- Gamal Esmat
10. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients
- Chia-Chi Wang
- Chen-Hua Liu
- Chih-Lin Lin
- Pin-Chao Wang
- Tai-Chung Tseng
- Hans Hsienhong Lin
- Jia-Horng Kao
11. Predictors of Chronic Hepatitis C Evolution in HIV Co-Infected Patients From Romania
- Camelia Sultana
- Simona Manuela Erscoiu
- Camelia Grancea
- Emanoil Ceausu
- Simona Ruta
12. Performance of machine learning approaches on prediction of esophageal varices for Egyptian chronic hepatitis C patients
- Shimaa M. Abd El-Salam
- Mohamed M. Ezz
- Somaya Hashem
- Wafaa Elakel
- Rabab Salama
- Hesham ElMakhzangy
- Mahmoud ElHefnawi
13. Serum Elabela Level as a Reliable Biomarker for Predicting of Liver Fibrosis in Iraqi Patients with Chronic Hepatitis C
- Eham Amer Ali
- Ali Abdulateef Hasan Al-Bayati
- Alea Farhan Salman
14. Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease
- Cheryl Huang
- Jun Jie Seah
- Chin Kimg Tan
- Jia Wen Kam
- Jessica Tan
- Eng Kiong Teo
- Andrew Kwek
- Yu Jun Wong
- Malcolm Tan
- Tiing Leong Ang
- Rahul Kumar
15. Exploring associations between pregnancy cravings and sociodemographic, lifestyle and health factors: insights from a cross-sectional population study in Jordan
- Suad M Kloub
- Saleem A Banihani
16. Clinical impact of serum α-fetoprotein and its relation on changes in liver fibrosis in hepatitis C virus patients receiving direct-acting antivirals
- Rabab Fouad
- Aisha Elsharkawy
- Shereen Abdel Alem
- Mohamed El Kassas
- Mohamed Alboraie
- Ahmad Sweedy
- Shimaa Afify
- Zeinab Abdellatif
- Marwa Khairy
- Gamal Esmat
17. Comparing the efficiency of Fib‐4, Egy‐score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C
- Ahmed Cordie
- Ahmed Salama
- Marwa El‐Sharkawy
- Saeed M. El‐Nahaas
- Marwa Khairy
- Aisha Elsharkawy
- Mohamed Hassany
- Gamal Esmat
18. Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore
- Yue Zhao
- Prem Harichander Thurairajah
- Rahul Kumar
- Jessica Tan
- Eng Kiong Teo
- John Chen Hsiang
19. Derivation of “Egyptian varices prediction (EVP) index”: A novel noninvasive index for diagnosing esophageal varices in HCV Patients
- Shimaa M. Abd-Elsalam
- Mohamed M. Ezz
- Shehab Gamalel-Din
- Gamal Esmat
- Wafaa Elakel
- Mahmoud ElHefnawi
20. Validation of a machine learning approach using FIB-4 and APRI scores assessed by the metavir scoring system: A cohort study
- Ahmed Hashem
- Abubakr Awad
- Hend Shousha
- Wafaa Alakel
- Ahmed Salama
- Tahany Awad
- Mahasen Mabrouk
21. The Efficacy of aHansenula-Derived 20 kDa Pegylated Interferon Alpha-2a in the Treatment of Genotype 4 Chronic Hepatitis C
- Hany Shehab
- Tamer Elbaz
- Dalia Deraz
- Amal Hafez
- Inas Elattar
22. Liver Biopsy Versus Non-Invasive Tests in Determining Liver Disease Status
- Seyed Moayed Alavian
23. Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
- Roger Chou
- Ngoc Wasson
24. Simple predictors of nonresponse to direct-acting antivirals in chronic hepatitis C patients
- Hend Ibrahim Shousha
- Yasmin Saad
- Doa’a A. Saleh
- Hosam Dabes
- Magdy Alserafy
- Yehia ElShazly
- Mohamed Said
25. The Impact of Interleukin 28b Gene Polymorphism on the Virological Response to Combined Pegylated Interferon and Ribavirin Therapy in Chronic HCV Genotype 4 Infected Egyptian Patients Using Data Mining Analysis
- Marwa Khairy
- Rabab Fouad
- Mahassen Mabrouk
- Wafaa El-Akel
- Abu Bakr Awad
- Rabab Salama
- Mayada Elnegouly
- Olfat Shaker